What's in Prism Health North Texas's pipeline?

Prism Health North Texas has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Prism Health North Texas's portfolio?

Top competitors by shared drug class: Central Institute of Epidemiology, Moscow, Russia, Harvard School of Public Health (HSPH), Hospital Universitari Vall d'Hebron Research Institute, Juan A. Arnaiz, National Center for AIDS/STD Control and Prevention, China CDC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/prism-health-north-texas.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Prism Health North Texas — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prism Health North Texas pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
DOR/3TC/TDF	DOR/3TC/TDF	marketed	Antiretroviral combination therapy (NNRTI + NRTI + NtRTI)	HIV reverse transcriptase	Infectious Disease / Virology
BIC/FTC/TAF	BIC/FTC/TAF	marketed	Antiretroviral combination therapy (integrase inhibitor + nucleoside reverse transcriptase inhibitors)	HIV integrase, HIV reverse transcriptase	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Central Institute of Epidemiology, Moscow, Russia · 1 shared drug class
Harvard School of Public Health (HSPH) · 1 shared drug class
Hospital Universitari Vall d'Hebron Research Institute · 1 shared drug class
Juan A. Arnaiz · 1 shared drug class
National Center for AIDS/STD Control and Prevention, China CDC · 1 shared drug class
St Stephens Aids Trust · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Prism Health North Texas:

Cite this brief

Drug Landscape (2026). Prism Health North Texas — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/prism-health-north-texas. Accessed 2026-05-16.